IRIS Institutional Research Information System - OPENBS Open Archive UniBS

TABELLINI, Giovanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.237
EU - Europa 2.896
AS - Asia 2.885
SA - Sud America 532
AF - Africa 36
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 8
Totale 11.602
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.172
CN - Cina 1.315
PL - Polonia 945
SG - Singapore 765
UA - Ucraina 557
BR - Brasile 461
FR - Francia 333
HK - Hong Kong 268
IT - Italia 260
DE - Germania 252
VN - Vietnam 170
FI - Finlandia 125
GB - Regno Unito 117
IN - India 105
RU - Federazione Russa 104
TR - Turchia 99
IE - Irlanda 89
SE - Svezia 43
CA - Canada 42
AR - Argentina 30
KR - Corea 24
BD - Bangladesh 22
ID - Indonesia 19
ZA - Sudafrica 17
MX - Messico 15
IQ - Iraq 14
NL - Olanda 13
SA - Arabia Saudita 13
BE - Belgio 12
EC - Ecuador 12
AT - Austria 11
ES - Italia 9
JP - Giappone 9
AU - Australia 8
CO - Colombia 8
CZ - Repubblica Ceca 7
IR - Iran 7
PK - Pakistan 7
AZ - Azerbaigian 6
EU - Europa 6
PE - Perù 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
LT - Lituania 5
MA - Marocco 5
PY - Paraguay 5
EG - Egitto 4
IL - Israele 4
KZ - Kazakistan 4
MU - Mauritius 4
VE - Venezuela 4
CL - Cile 3
HN - Honduras 3
LB - Libano 3
LV - Lettonia 3
OM - Oman 3
TN - Tunisia 3
UY - Uruguay 3
CR - Costa Rica 2
DZ - Algeria 2
IM - Isola di Man 2
KG - Kirghizistan 2
MY - Malesia 2
NP - Nepal 2
PH - Filippine 2
PS - Palestinian Territory 2
RO - Romania 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
MN - Mongolia 1
TH - Thailandia 1
TJ - Tagikistan 1
Totale 11.602
Salva come PNG Salva come JPEG
Città #
Warsaw 943
Fairfield 722
Woodbridge 552
Houston 436
Ashburn 426
Shenzhen 407
Jacksonville 395
Singapore 363
Cambridge 274
Seattle 268
Wilmington 266
Hong Kong 265
Ann Arbor 245
Beijing 232
Princeton 166
Brescia 152
New York 141
Chandler 133
Nanjing 118
The Dalles 96
Dublin 87
Dearborn 79
Los Angeles 73
Istanbul 71
Nanchang 69
Ho Chi Minh City 51
Moscow 51
Shenyang 46
Helsinki 43
São Paulo 43
Des Moines 38
San Diego 37
Buffalo 36
Munich 36
Changsha 35
Dallas 33
Hebei 32
Jinan 31
Hanoi 30
San Francisco 30
Chicago 27
Tianjin 27
London 26
Redondo Beach 26
Dong Ket 24
Jiaxing 22
Milan 22
Ningbo 20
Shanghai 20
Taizhou 20
Seongnam 19
Toronto 17
Montreal 16
Santa Clara 16
Jakarta 15
Kunming 14
Rio de Janeiro 14
Turku 14
Zhengzhou 14
Brasília 13
Denver 13
Kocaeli 13
Verona 12
Augusta 11
Phoenix 11
Hangzhou 10
Indianapolis 10
Brussels 9
Johannesburg 9
Brooklyn 8
Campinas 8
Chennai 8
Haikou 8
Riyadh 8
Tokyo 8
Atlanta 7
Haiphong 7
Lancaster 7
Salvador 7
Sydney 7
Washington 7
Amsterdam 6
Baku 6
Belo Horizonte 6
Boardman 6
Charlotte 6
Cremona 6
Da Nang 6
Mexico City 6
Mumbai 6
Orem 6
Quito 6
Stockholm 6
Tashkent 6
Vienna 6
Baghdad 5
Betim 5
Brno 5
Bắc Giang 5
Council Bluffs 5
Totale 8.234
Salva come PNG Salva come JPEG
Nome #
Occurrence of nodular lymphocyte-predominant hodgkin lymphoma in hermansky-pudlak type 2 syndrome is associated to natural killer and natural killer T cell defects. 560
A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP 351
Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations 335
NFKB1 regulates human NK cell maturation and effector functions 316
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. 280
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 274
Targeting the PI3K/Akt/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potential 273
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia. 237
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 206
Clinical, laboratory and molecular signs of immunodeficiency in patients with partial oculo-cutaneous albinism. 199
The RAC2-PI3K axis regulates human NK cell maturation and function 187
Defective natural killer-cell cytotoxic activity in NFKB2-mutated CVID-like disease 184
CTLA-4 regulates human Natural Killer cell effector functions 176
A monoallelic activating mutation in RAC2 resulting in a combined immunodeficiency 173
Inherited DOCK2 deficiency in patients with early-onset invasive infections 168
Effects of opioid therapy on human natural killer cells. 166
Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway. 153
A threonine 308 phosphorylated form of Akt translocates to the nucleus of PC12 cells under nerve growth factor stimulation and associates with the nuclear matrix protein nucleolin. 152
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content. 145
Phosphoinositide 3-kinase/Akt inhibition increases arsenic trioxide-induced apoptosis of acute promyelocytic and T-cell leukaemias 143
Primitive neuroectodermal tumor in an ovarian cystic teratoma: natural killer and neuroblastoma cell analysis 141
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer. 141
Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: eliminating activity by targeting at different levels 140
Re-examination of the mechanisms regulating nuclear inositol lipid metabolism. 138
Flow cytometric detection of total and serine 473 phosphorylated Akt. 137
Diacylglycerol kinases in nuclear lipid-dependent signal transduction pathways 136
Proliferating or differentiating stimuli act on different lipid-dependent signaling pathways in nuclei of human leukemia cells. 134
Rab3A and Rab3D control the total granule number and the fraction of granules docked at the plasma membrane in PC12 cells 134
A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells. 132
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: Targeting the unfolded protein response signaling 130
Nuclear changes in necrotic HL-60 cells. 129
Intranuclear distribution of HMGI/Y proteins. An immunocytochemical study 127
Influence of different metal ions on the ultrastructure, biochemical properties, and protein localization of the K562 cell nuclear matrix. 124
The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretion. 124
The emerging multiple roles of nuclear Akt 124
Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia. 123
Exome sequencing reveals a pallidin mutation in a Hermansky-Pudlak-like primary immunodeficiency syndrome 123
GPR56 as a novel marker identifying the CD56dull CD16+ Nk cell subset both in blood stream and in inflamed peripheral tissues 122
The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression. 120
Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia. 120
Nuclear apoptotic changes: an overview 120
Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells. 119
The role of chemerin in the co-localization of NK and dendritic cell subsets into inflamed tissues. 119
Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivation 118
The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells 117
From Natural Killer Cell Receptor Discovery to Characterization of Natural Killer Cell Defects in Primary Immunodeficiencies 117
Localization of the small monomeric GTPases Rab3D and Rab3A in the AtT-20 rat pituitary cell line. 116
PI3K/AKT/mTORC1 and MEK/ERK signaling in T-cell acute lymphoblastic leukemia: New options for targeted therapy. 116
Severe impairment of IFN-γ and IFN-α responses in cells of a patient with a novel STAT1 splicing mutation. 115
Nuclear lipids: new functions for old molecules? 114
Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulation. 114
Intraepidermal Injections of Autologous Epidermal Cell Suspension: A new promising approach to Dermatological Disorders. Preliminary Study 114
Novel 2'-substituted, 3'-deoxy-phosphatidyl-myo-inositol analogues reduce drug resistance in human leukaemia cell lines with an activated phosphoinositide 3-kinase/Akt pathway. 114
Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor Perifosine in acute myelogenous leukemia cells. 111
Further considerations on the intranuclear distribution of HMGI/Y proteins. 111
Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia 106
The pro-apoptotic drug camptothecin stimulates phospholipase D activity and diacylglycerol production in the nucleus of HL-60 human promyelocytic leukemia cells. 102
Response to the Letter to the Editor Regarding “Functional evaluation of natural killer cell cytotoxic activity in NFKB-2 mutated patients” 99
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors 99
Characterization of a new patient with STAT1 deficiency: new insights into IFNs signal transduction pathways 97
Diacylglycerol kinase-theta is localized in the speckle domains of the nucleus. 96
CARD11 dominant negative mutation leads to altered human Natural Killer cell homeostasis 94
Exome Sequencing Reveals a Pallidin Mutation in a Hermansky-Pudlak-Like Primary Immunodeficiency Syndrome 94
Phosphoinositide-specific phospholipase Cbeta1 expression is not linked to nerve growth factor-induced differentiation, cell survival or cell cycle control in PC12 rat pheocromocytoma cells. 94
Activity of the selective IκB kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia: Involvement of FOXO3a. 94
Combined immunodeficiency with autoimmunity caused by a homozygous missense mutation in inhibitor of nuclear factor κB kinase alpha (IKKα) 94
Involvement of the phosphoinositide 3-kinase/Akt signaling pathway in the resistance to therapeutic treatments of human leukemias. 92
Nuclear expression of diacylgycerol kinases: possibile involvement in DNA replication 91
The phosphoinositide 3-kinase/AKT1 pathway involvement in drug and all-trans-retinoic acid resistance of leukemia cells. 90
Enhanced nuclear diacylglycerol kinase activity in response to a mitogenic stimulation of quiescent Swiss 3T3 cells with insulin-like growth factor I. 90
Binding of elements of protein kinase C-alpha regulatory domain to lamin B1 89
P85α is an intrinsic regulator of human natural killer cell effector functions 89
Natural killer cell impairment in ovarian clear cell carcinoma 87
The controversial nuclear matrix: a balanced point of view. 86
Erythropoietin-induced erythroid differentiation of K562 cells is accompanied by the nuclear translocation of phosphatidylinositol 3-kinase and intranuclear generation of phosphatidylinositol (3,4,5) trisphosphate. 85
Intranucleolar localization of DNA topoisomerase IIalpha is a distinctive feature of necrotic, but not of apoptotic, Jurkat T-cells. 84
Nuclear matrix protein is released from apoptotic white cells during cold (1-6 degrees C) storage of concentrated red cell units and might induce antibody response in multiply transfused patients. 83
Rabphilin localizes with the cell actin cytoskeleton and stimulates association of granules with F-actin cross-linked by {alpha}-actinin. 83
Molecular characterization of protein kinase C-alpha binding to lamin A. 82
Insulin-like growth factor-I-dependent stimulation of nuclear phospholipase C-beta1 activity in Swiss 3T3 cells requires an intact cytoskeleton and is paralleled by increased phosphorylation of the phospholipase. 78
Nuclear phosphoinositide specific phospholipase C (PI-PLC)-beta 1: a central intermediary in nuclear lipid-dependent signal transduction. 78
Lack of iNKT Cells and Defects on Differentiation of Dendritic Cells in Patients with Hermansky-Pudlak Type 2 Syndrome (HPS2) 78
Nuclear diacylglycerol kinases: emerging downstream regulators in cell signaling networks. 75
Nuclear diacylglycerol kinase-theta is activated in response to nerve growth factor stimulation of PC12 cells. 75
Lack of DOCK8 impairs the primary biologic functions of human NK cells and abrogates CCR7 surface expression in a WASP-independent manner 67
FGF-trapping hampers cancer stem-like cells in uveal melanoma 58
Remission Status at Transplantation and Treatment History Determine the Survival Chances of Patients after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia Who Had Received Pre-Treatment with Idelalisib: A Report from the EBMT Chronic Malignancies Working Party 57
The novel XIAP Lys396Ter variant alters mitochondrial membrane potential and endoplasmic reticulum intensity in monocytes of two XIAP-deficient patients. 6
PD-1+ NK cell subsets in high grade serous ovarian cancer: an indicator of disease severity and a target for combined immunecheckpoint blockade 6
Totale 11.790
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.133
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.133
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021911 0 0 0 0 0 138 69 146 200 130 168 60
2021/2022827 61 158 21 56 15 32 38 50 34 97 66 199
2022/2023519 125 1 3 31 33 146 5 52 59 1 28 35
2023/20241.004 36 11 462 27 17 130 32 25 163 2 8 91
2024/20251.405 11 3 6 184 155 110 119 48 158 113 332 166
2025/20261.775 269 395 260 515 306 30 0 0 0 0 0 0
Totale 11.790